MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$899K
Net Income
-$5,485K
Net Profit Margin
-610.12%
EPS
-$0.04
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Product sales, net
899 9,561 4,952 4,825
Cost of goods sold
410 2,592 905 755
Amortization of intangible asset
NaN NaN NaN 107
Loss on change in accounting estimates on contingent royalty liability (note 7)
NaN -3,866* 1,933 NaN
Amortization of intangible asset
75 96 80 100
Research and development, net
518 -3,501* 470 746
Selling and marketing
2,093 2,066 2,391 2,625
General and administrative
2,372 1,097 2,088 1,843
Total operating expenses
5,468 6,216 4,001 6,076
Income (loss) from operations
-4,569 3,345 951 -1,251
Interest income
2 2 3 2
Gain on debt extinguishment, net
NaN NaN NaN 0
Loss on issuance of financial instruments
NaN NaN NaN 0
Other expense, net
737 691 682 662
Change in fair value of financial instruments
-162 131 -1,845 134
Total other income (expense), net
-897 -558 -2,524 -526
Income (loss) before income tax expense
-5,466 2,787 -1,573 -1,777
Income tax expense
-1 -1 -4 7
Net income (loss)
-5,465 2,788 -1,569 -1,784
Convertible and redeemable preferred stock deemed dividends
20 2 111 -1
Net income (loss) attributable to common stockholders
-5,485 2,786 -1,680 -1,785
Basic EPS
-0.04 0.019 -0.01 -0.02
Diluted EPS
-0.04 0 -0.01 -0.02
Basic Average Shares
133,246,864 146,011,189 119,578,093 115,686,024
Diluted Average Shares
133,246,864 6,421,746,555* 119,578,093 115,686,024
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net income (loss)attributable to common...-$5,485K (-675.55%↓ Y/Y)Net income (loss)-$5,465K (-671.65%↓ Y/Y)Convertible and redeemablepreferred stock deemed...$20K (766.67%↑ Y/Y)Income tax expense-$1K Income (loss) beforeincome tax expense-$5,466K (-671.76%↓ Y/Y)Income (loss) fromoperations-$4,569K (-1497.25%↓ Y/Y)Total other income(expense), net-$897K (-242.61%↓ Y/Y)Product sales, net$899K (6.39%↑ Y/Y)Interest income$2K (-75.00%↓ Y/Y)Total operatingexpenses$5,468K (955.60%↑ Y/Y)Other expense, net$737K (22.83%↑ Y/Y)Change in fair value offinancial instruments-$162K (-113.27%↓ Y/Y)General andadministrative$2,372K (0.30%↑ Y/Y)Selling and marketing$2,093K (-19.50%↓ Y/Y)Research anddevelopment, net$518K (110.29%↑ Y/Y)Cost of goods sold$410K (12.33%↑ Y/Y)Amortization of intangibleasset$75K (-66.37%↓ Y/Y)

Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences, Inc. (EVFM)